Welcome to epgonline.org - the website for healthcare professionals

What's new?

  • ,What's New Survey

    Have your say!

    epgonline.org is conducting a survey with healthcare professionals to gain valuable insights
    which will help providers of medical information to better understand and cater to your needs.
    Please spare 10-15 minutes of your time to answer 20 questions, which are primarily
    multiple-choice format.

    Your personal details will remain completely confidential.

  • ,AIKN CDI May Update

    Anti-Infectives Knowledge Network (AIKN) CDI Updates

    The Anti-Infectives Knowledge Network – Clostridium difficile infection (AIKN-CDI) has
    recently been updated with new content including presentation slides from EBMT and
    ECCMID 2015, a gut microflora animation unveiled at the Astellas stand during
    ECCMID 2015, recent articles added to the ‘CDI perspectives’ section and the
    opportunity to participate in a second round consensus questionnaire for the
    ​largest ever clinician consensus report.

    May 2015 MYC/15/0020/EUb

  • ,Whats New CSU

    Launch of Chronic Spontaneous Urticaria (CSU)
    Knowledge Centre

    A new Chronic Spontaneous Urticaria (CSU) Knowledge Centre has
    launched on epgonline.org to raise awareness and improve early diagnosis
    of the condition. Healthcare professionals will have free access to a
    disease overview, recent symposia highlights, a video channel and useful resources.

  • ,Whats new Psoriasis Knowledge centre

    Launch of Psoriasis Knowledge Centre

    A new Psoriasis Knowledge Centre has launched on epgonline.org
    to provide dermatologists, family medicine physicians and other healthcare
    professionals with free access to relevant information on psoriasis including
    pathophysiology, comorbidities, signs and symptoms, diagnosis and more.

  • ,What's New ECCMID IFI

    Anti-Infectives Knowledge Network (AIKN) IFI Updates

    The AIKN-IFI has been updated with four presentations from the Astellas-sponsored
    symposium at the 25th European Congress of Clinical Microbiology and Infectious
    Diseases (ECCMID) 2015
    . The congress took place on 25–28 April in Copenhagen,
    Denmark. Visit the congresses section of this resource to view and download the slides
    free of charge.

    May 2015 MYC/15/0040/EUb

Latest News

Have your say! Take the epgonline.org survey investigating the online medical content needs of healthcare professionals


epgonline.org is conducting a short survey to help improve the quality of online medical content available to healthcare professionals across all countries and medical specialties. We would be grateful if you could spare 15-20 minutes of your ...

Single tablet emtricitabine + tenofovir alafenamide + rilpivirine submitted to FDA for HIV/AIDS-Gilead Sciences/Janssen


Gilead Sciences has submitted a New Drug Application to the FDA for an investigational, once-daily single tablet regimen that combines Gilead’s emtricitabine 200 mg and tenofovir alafenamide (TAF) 25 mg with rilpivirine 25 mg (R/F/TAF) from Janssen ...

Positive data from study of SIR-Spheres Microspheres in colorectal cancer-Sirtex


Adding SIR-Spheres Y-90 resin microspheres, from Sirtex, to first-line chemotherapy for patients with unresectable metastatic colorectal cancer in the liver (mCRC) further extends Progression-Free Survival in that organ. Patients with mCRC that has ...

Continuous Intravascular Glucose Monitoring System achieves CE Mark-GlySure Limited


GlySure Limited has announced that it has secured the CE Mark for the world’s first and only Continuous Intravascular Glucose Monitoring System (CIGMS). The initial use of the GlySure CIGMS is to enhance blood glucose management among adult cardiac ...

FDA approves Restylane Lyft for cheek augmentation- Galderma


Galderma announced that it has received FDA approval to market Restylane Lyft for cheek augmentation and the correction of age-related midface contour deficiencies in patients over the age of 21. Restylane Lyft, formerly marketed as Perlane-L, is ...

Novartis faces $3.5 billion US lawsuit for false claims under Medicare and Medicaid


Novartis are being investigated by the US Justice Department and 12 States in a False Claims Act lawsuit claiming $3.4 billion based on false Medicare and Medicaid claims related to alleged kickbacks and more than $500 million government payements ...

Panther Biotechnology acquires Alchemia Oncology Pty Limited and with it HA-Irinotecan


Panther Biotechnology, Inc. a biotechnology company specializing in the acquisition and development of enhanced therapeutics for the treatment of neoplastic, autoimmune and antiviral disorders, announced that it has entered into an agreement to ...

Recent Updates


Clinical Guidelines

Anaemia management in people with chronic kidney disease

Lower urinary tract symptoms: The management of lower urinary tract symptoms in men

Suspected cancer: recognition and referral (NG12)

NICE diagnostics guidance [DG17]

Medical Journals

Three-Year Outcomes of Bariatric Surgery vs Lifestyle Intervention for Type 2 Diabetes Mellitus Treatment: A Randomized Clinical Trial.

Consequences of AphanizomenonFlos-aquae(AFA) extract (Stemtech (TM) ) on metabolic profile of patients with type 2 diabetes.

Cognitive existential couple therapy (CECT) in men and partners facing localised prostate cancer: a randomised controlled trial.

Circulating tumor cell biomarker panel as an individual-level surrogate for survival in metastatic castration-resistant prostate cancer.,Circulating tumor cell biomarker panel as an individual-level surrogate for survival in metastatic castration-resistant prostate cancer.

epgonline.org Social

Disease Topics

Disease Topics

48 Disease areas packed with insight

Disease Topics

Knowledge Centres

Diagnosis, patient management, treatment strategies & decision support

Drug Database

Drug Database

Summary information on thousands of prescription drugs available in 9 languages



News written for doctors around pharmacological development

Treatment Guidelines

Clinical Guidelines

Professional association and governmental guidance on treatment

Disease Topics

Clinical Trials

Medical research & drug development - current and past landmark studies

Medical Journals

Medical Journals

Journal articles, titles and extracts from respected publishers

Disease Topics

Medical Apps

All the latest free and paid-for Apps selected for doctors